Bohen Sean 4
4 · Olema Pharmaceuticals, Inc. · Filed Feb 2, 2023
Insider Transaction Report
Form 4
Bohen Sean
DirectorPRESIDENT AND CEO
Transactions
- Award
Stock Option (Right to Buy)
2023-02-01+550,000→ 550,000 totalExercise: $4.87Exp: 2033-01-31→ Common Stock (550,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on February 1, 2024 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.